J code, description of code and brand name of factor, total units or mg Riabni. Yes. SOL. Anti-neoplastic. None. X. X. X. Effective
Manufacturer: Amgen ; Riabni HCPCS: Q5123 ; Q5123 Effective Date: J ; HCPCS Code Descriptor: Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
code blue (or code), in hospital, 337 codeine classification, dose, 795mt Riabni (rituximab-arrx), 671mt, 704mt. Riax (benzoyl peroxide), 739mt.
Rituximab-arrx Injection, for Intravenous Use (Riabni) HCPCS Code J3590: Billing Guidelines Adult patients with non-Hodgkin's Lymphoma (NHL).
riabni, 10 mg,, Not Covered, Not Covered, 0, 0%, 0%, 0%, 9, 9, 9, 9, 9, 9, X. Refer to Field HCPCS Code, HCPCS Code, HCPCS Code, HCPCS Code, HCPCS
Rituximab (Rituxan, Truxima, Ruxience Riabni). Rituximab is J Clin Oncol 2024;28(10): . 2. Hallek M, Fischer K, Fingerle
Riabni), the third biosimilar version of Rituxan for NHL, CLL, GPA, and MPA. Coding. See CPT/HCPCS Code section below. Policy/ Coverage: For members of plans
Bill type 131, Revenue code 905 or 912, CPT code , S9480, HCPCS code H2024 Q5123 rituximab-arrx (Riabni). Q5124 ranibizumab-nuna
Added HCPCS code C9070. Interim Review, approved Janu. Added the biosimilar Riabni (rituximab- arrx) as
R.